FOXP1 and myocardial infarction: In contrast to Foxp1 deletion in CMs, Foxp1 gain‐of‐function using transgenic Foxp1CMTg mice (Figure S4A–C, Supporting Information) triggered a statistically significant reduced capacity of heart regeneration in neonatal AR and adult MI models.